References
- Martini GA, Knauff HG, Schmidt HA, Mayer G, Baltzer G. A hitherto unknown infectious disease contracted from monkeys. “Marburg virus” disease. Ger. Med. Mon.13, 457–470 (1968).
- Bres P. [The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note.] Bull. World Health Organ.56, 245 (1978).
- Pattyn S, van der Groen G, Courteille G, Jacob W, Piot P. Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet1, 573–574 (1977).
- Agafonova OA, Viazunov SA, Zhukov VA et al. [Relationship between the level of specific antibodies with disease outcome in Cercopithecus aethiops monkeys in experimental Marburg disease]. Vopr. Virusol.42, 109–111 (1997).
- Jones SM, Feldmann H, Stroher U et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med.11, 786–790 (2005).
- Sullivan NJ, Geisbert TW, Geisbert JB et al. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. PLoS. Med.3, e177 (2006).
- Sullivan NJ, Geisbert TW, Geisbert JB et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature424, 681–684 (2003).
- Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature408, 605–609 (2000).
- Martin JE, Sullivan NJ, Enama ME et al. A DNA vaccine for Ebola virus is safe immunogenic in a Phase I clinical trial. Clin. Vaccine Immunol.13(11), 1267–1277 (2006).
- Daddario-DiCaprio KM, Geisbert TW, Stroher U et al. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet367, 1399–1404 (2006).
- Okware SI, Omaswa FG, Zaramba S et al. An outbreak of Ebola in Uganda. Tropical Med. Intl. Health7, 1068–1075 (2002).
- Kapp C. Surge in polio spreads alarm in northern Nigeria. Lancet362, 1631 (2003).
- WHO. Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April – June 2004. Wkly Epidemiol. Rec.80, 370–375 (2005).
- WHO.Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001–July 2002. Wkly Epidemiol. Rec.78, 223–228 (2003).
- WHO. Marburg fever, Democratic Republic of the Congo. Wkly Epidemiol. Rec.74, 145 (1999).
- WHO. Marburg haemorrhagic fever, Angola – update. Wkly Epidemiol. Rec.80, 141–142 (2005).
- Geisbert TW, Hensley LE, Jahrling PB et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet362, 1953–1958 (2003).